This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
by Zacks Equity Research
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
BSXPositive Net Change DGXPositive Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
by Zacks Equity Research
ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.
BSXPositive Net Change ALCNegative Net Change MEDPNegative Net Change WGSPositive Net Change
earnings medical medical-devices
Should You Buy Materion (MTRN) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MTRNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Mueller Water Products (MWA)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MWANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Grab These 4 Stocks With Solid Net Profit Margins to Boost Returns
by Anirudha Bhagat
Boost your portfolio with GLDD, INFU, TILE and CENX, each showing strong net profit margins and rising EPS estimates.
GLDDPositive Net Change CENXPositive Net Change TILENegative Net Change INFUNegative Net Change
basic-materials industrial-products medical medical-devices
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring
by Zacks Equity Research
MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.
BSXPositive Net Change MASINegative Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
GEHC Positioned for Growth With AI, Global Expansion and Margins
by Zacks Equity Research
GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.
ABTPositive Net Change BSXPositive Net Change PHGNegative Net Change GEHCNegative Net Change
medical medical-devices
DexCom Expands Access and Innovation While Balancing Headwinds
by Zacks Equity Research
DXCM grows on type 2 access, Stelo adoption, and new sensor launches, but faces margin pressures, competition and leadership transition.
ABTPositive Net Change RHHBYPositive Net Change MDTPositive Net Change DXCMNegative Net Change
medical medical-devices
Polaris Inc (PII) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PIIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Wex (WEX)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WEXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
by Moumi Mondal
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
RHHBYPositive Net Change DGXPositive Net Change HOLXNegative Net Change
medical medical-devices
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
by Zacks Equity Research
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change NMTCNegative Net Change
medical medical-devices
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
by Debanjana Dey
HIMS eyes long-term growth with new hormonal health offerings, international expansion and high GLP-1 retention.
AMWLPositive Net Change HIMSNegative Net Change LFMDNegative Net Change
medical medical-devices
Should You Buy LendingClub (LC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Williams-Sonoma (WSM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
WSMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sally Beauty (SBH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SBHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds
by Zacks Equity Research
COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.
BSXPositive Net Change COOPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices
ISRG's International Push for Ion: Strategic Bet or Overstretch?
by Indrajit Bandyopadhyay
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
JNJNegative Net Change MDTPositive Net Change ISRGPositive Net Change
medical medical-devices
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
by Zacks Equity Research
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
BSXPositive Net Change LHPositive Net Change IDXXNegative Net Change NVSTNegative Net Change
medical medical-devices
Top Stock Reports for IBM, Goldman Sachs & Thermo Fisher
by Mark Vickery
IBM beats Q2 estimates with hybrid cloud and AI growth, but faces consulting weakness and macro headwinds.
GSNegative Net Change TUPositive Net Change IBMNegative Net Change TMOPositive Net Change ENBPositive Net Change RDDTPositive Net Change
computers finance medical-devices
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
by Zacks Equity Research
NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.
NRXSPositive Net Change
earnings medical medical-devices
Should You Buy Dorman Products (DORM) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DORMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy TPG RE Finance Trust (TRTX) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TRTXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
QUBT Q2 Earnings Match Estimates, Revenues Miss, Stock Down
by Zacks Equity Research
Quantum Computing posts a wider loss, and revenues lag estimates. However, milestones in quantum tech, NASA contract and index inclusion mark growth steps.
ACLSPositive Net Change LDOSPositive Net Change ANETPositive Net Change QUBTNegative Net Change
earnings medical medical-devices
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
by Zacks Equity Research
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
RMDPositive Net Change LIVNPositive Net Change INSPNegative Net Change NYXHNegative Net Change
medical medical-devices